Promoted Companies
SORT BY:
CytRx Corporation (CYTR)
| Total paid for Promotions this month: | $0 | ||
| E-mails this Month: | 1 | ||
| Estimated Volume Generated: | $0 | ||
| Research Report on CYTR: | Click to see | ||
| * The information presented is based on information for May , 2014 | |||
Positive Interim Results from Soft Tissue Sarcoma Trial May 28, 2014 08:21
Positive Interim Results from Soft Tissue Sarcoma Trial
CytRx Corporation (CYTR)
A sarcoma is a type of cancer that begins in any part of the body, such as the bone or soft tissue. Soft tissue sarcomas can develop from soft tissues like fat, muscle, nerves, fibrous tissues, blood vessels, or deep skin tissues. They can arise anywhere in the body at any age.
The American Cancer Society's estimates for soft tissue sarcomas
...read more
| Promoter: | pennyomega.com | Paying Party: | UNKNOWN |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| CYTR | Unknown compensation | UNKNOWN |
| Max Profit: 0.47 % | Gain at close: -3.28 % |
CytRx Corp. (CYTR) - Tip of the Week Dec 16, 2013 08:31
CytRx Corp. (CYTR)
CytRx Corp., a biopharmaceutical research and development company, specializes in the enhanced delivery of proven oncology therapies to treat cancer. The company's novel linker platform technology can be utilized with multiple chemotherapeutic agents and could allow for greater concentration of drug at tumor sites while minimizing side effects.
View The Full Company Profile
Boston Therapeutics, Inc. (BTHE)
...read more
| Promoter: | Tip.us | Paying Party: | No Third Party |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| CYTR | $30,000 | UNKNOWN |
| Max Profit: 1.39 % | Gain at close: -10.28 % |
CYTR an 208% Increase in PPS From Our Alert at 2.20 Dec 15, 2013 11:59
GSA CYTR an 208% Increase in PPS From Our Alerted Price
www.GreatStockAlerts.com
Good Morning Traders,
CYTR turned out to be a phenomenal pick for our traders, printing share prices as high as 6.79 per shares after our November alert at 2.20. All together that's an 208% increase in share price from our emailed alert.
Stay tuned for more great stock due diligence and trading ideas
...read more
| Promoter: | @PennyStockAlerts | Paying Party: | UNKNOWN |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| CYTR | Unknown compensation | UNKNOWN |
| Max Profit: 58.21 % | Gain at close: 52.24 % |
BullQuake Alerts - CYTR Prints 6.36 an 186% Increase in Share Price Dec 12, 2013 21:16
BullQuake Alerts - CYTR Prints 6.36 an 186% Increase in Share Price
www.BullQuake.com
Good Evening Traders and Investors,
CYTR Prints 6.36 an 186% Increase in Share Price
We would like to congratulate our traders on a great trade just in time for Christmas. CytRX (CYTR) continued its bullish movement throughout today's trading session upon yesterday announcement
...read more
| Promoter: | BullQuake | Paying Party: | UNKNOWN |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| CYTR | Unknown compensation | UNKNOWN |
| Max Profit: 3.50 % | Gain at close: 2.72 % |
GSA CYTR Released Positive Results, Soared Over 99% From our Alert! Dec 11, 2013 17:10
GSA CYTR Released Positive Results, Soared Over 99% From our Alert!
www.GreatStockAlerts.com
Good Afternoon Traders,
I believe a congratulations is in order!
This morning CYTR traded up as high as 4.38 per share which is over 99% from our profiled alert from mid/late November!! The company released positive results for their Global Phase 2B Clinical Trials as we predicted..
...read more
| Promoter: | @PennyStockAlerts | Paying Party: | UNKNOWN |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| CYTR | Unknown compensation | UNKNOWN |
| Max Profit: 58.21 % | Gain at close: 52.24 % |
BullQuake Alerts - CYTR Up Over 99% on Positive Results for Global... Dec 11, 2013 16:58
BullQuake Alerts - CYTR Up Over 99% on Positive Results for Global Phase 2B Clinical Trials
www.BullQuake.com
Good Afternoon Traders and Investors,
Congratulations on a great pick. As anticipated CYTR released positive results towards their Global Phase 2B Clinical Trial and in turn the pps went parabolic! CYTR yielded 99% in gains from our alerted pps.
CYTR printed
...read more
| Promoter: | BullQuake | Paying Party: | UNKNOWN |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| CYTR | Unknown compensation | UNKNOWN |
| Max Profit: 3.50 % | Gain at close: 2.72 % |
CBEH & CYTR are Up Over 75% and 20% Consecutively Dec 08, 2013 13:13
BullQuake Alerts - CBEH & CYTR are Up Over 75% and 20% Consecutively
www.BullQuake.com
Good Afternoon Traders and Investors,
We hope that everyone has been paying close attention to our blog and newsletter. Those who have, have been complementing us left and for our constant great trade ideas and due diligence. Below are recaps on two of our recent swing trade ideas
...read more
| Promoter: | BullQuake | Paying Party: | UNKNOWN |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| CYTR | Unknown compensation | UNKNOWN |
| Max Profit: 3.50 % | Gain at close: 2.72 % |
CytRx Corp. (CYTR) - Tip of the Week Sep 30, 2013 08:31
CytRx Corp. (CYTR)
CytRx Corp., a biopharmaceutical research and development company, specializes in the enhanced delivery of proven oncology therapies to treat cancer. The company's novel linker platform technology can be utilized with multiple chemotherapeutic agents and could allow for greater concentration of drug at tumor sites while minimizing side effects.
View The Full Company Profile
Calpian, Inc. (CLPI) International
...read more
| Promoter: | Tip.us | Paying Party: | No Third Party |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| CYTR | $30,000 | 2,629,808 |
| Max Profit: 1.39 % | Gain at close: -10.28 % |
PennyOmega.com Stocks In Action on Monday! Oct 31, 2011 15:06
CYTR, CytRx Corporation
CYTR announced favorable response and safety indications from a group of patients with advanced solid tumors in the Company’s ongoing Phase 1b/2 clinical trial with INNO-206, its tumor-targeting conjugate of the commonly used chemotherapeutic agent doxorubicin.
CYTR is a biopharmaceutical research and development oncology company engaged in the development of high-value human therapeutics.
...read more
| Promoter: | pennyomega.com | Paying Party: | UNKNOWN |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| CYTR | Unknown compensation | UNKNOWN |
| Max Profit: 12.22 % | Gain at close: -1.39 % |
PennyToBuck.com Stocks In Action on Monday! Oct 31, 2011 14:57
CYTR, CytRx Corporation
CYTR announced favorable response and safety indications from a group of patients with advanced solid tumors in the Company’s ongoing Phase 1b/2 clinical trial with INNO-206, its tumor-targeting conjugate of the commonly used chemotherapeutic agent doxorubicin.
CYTR is a biopharmaceutical research and development oncology company engaged in the development of high-value human
...read more
| Promoter: | penny to buck | Paying Party: | UNKNOWN |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| CYTR | Unknown compensation | UNKNOWN |
| Max Profit: 12.22 % | Gain at close: -1.39 % |